AKTS PBLS HIMS Today and tomorrow, an FDA advisory committee will mull whether compounding pharmacies should be allowed to manufacture seven

AKTS PBLS HIMS Today and tomorrow, an FDA advisory committee will mull whether compounding pharmacies should be allowed to manufacture seven peptides, in particular. This could mean a clash between career FDA scientists, newly appointed panelists with ties to prescribing peptides, and an HHS leadership that generally supports broader access to these substances - STAT News